Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04832854
Title A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Hoffmann-La Roche
Indications

lung non-small cell carcinoma

Therapies

Atezolizumab + Carboplatin + MTIG7192A + Pemetrexed Disodium

Atezolizumab + Carboplatin + MTIG7192A + Paclitaxel

Atezolizumab + MTIG7192A

Atezolizumab + Cisplatin + MTIG7192A + Pemetrexed Disodium

Atezolizumab + Carboplatin + Gemcitabine + MTIG7192A

Atezolizumab + Cisplatin + Gemcitabine + MTIG7192A

Cisplatin + Gemcitabine

Carboplatin + Gemcitabine

Carboplatin + Paclitaxel

Carboplatin + Pemetrexed Disodium

Cisplatin + Pemetrexed Disodium

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST